NIVF Stock Analysis: Buy, Sell, or Hold?
NIVF - NewGenIvf Group Limited Class A ordinary shares
$1.37
0.03 (2.24%)
▲
WAIT
LOW Confidence
Last Updated: January 30, 2026
Get Alerted When NIVF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
13 traders called NIVF this week
86% bullish • 3 bearish
86% bullish • 3 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: NIVF is 33.0% above fair value ($1.03). Market expects -42.7% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: NIVF is 33.0% above fair value ($1.03). Market expects -42.7% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$10.03
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$6.22
78.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 0.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NIVF is currently trading at $1.37, which is considered extended relative to its 30-day fair value range of $0.41 to $1.03. From a valuation perspective, the stock is trading at a discount (Forward PE: 0.1) compared to its historical average (0.3). Remarkably, the market is currently pricing in an annual earnings decline of 42.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NIVF is in a strong downtrend. Immediate support is located at $0.39, while resistance sits at $2.46.
Market Sentiment: NIVF has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $225.00 (+16691.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NIVF is in a strong downtrend. Immediate support is located at $0.39, while resistance sits at $2.46.
Market Sentiment: NIVF has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $225.00 (+16691.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$0.41 -
$1.03
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
Protect Your Profits
Holding NIVF? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+33.0% above fair value)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 16691.0% below Wall St target ($225.00)
- WARNING: Recommendation downgraded due to 33.0% overvaluation
Fair Price Analysis
30-Day Fair Range
$0.41 -
$1.03
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$0.39
Resistance Level
$2.46
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
0.06
Wall Street Target
$225.00
(+16691.0%)
Revenue Growth (YoY)
-12.9%
Profit Margin
381.2%
Valuation Discount vs History
-42.7% cheaper
PE vs Historical
0.1 vs 0.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-42.7%
(market-implied from PE analysis)
1-Year Target
$1.21
(-10%)
2-Year Target
$1.09
(-19%)
3-Year Target
$0.98
(-27%)
3-Yr Target (if PE normalizes)
(PE: 0→0)
$5.22
(+289%)
📈
Valuation based on Current Earnings
Trailing PE: 0.00 | Current EPS (TTM): $4195.34
Bull Case
$0.92
(-31%)
Analyst growth -50.0%, PE expands to 0.0
Base Case
$0.84
(-37%)
Market implied -50.0%, PE stable at 0.0
Bear Case
$1.14
(-15%)
Severe decline -20.0%, PE contracts to 0.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 0.1 to 0.3
Stabilization Target:
$7.16
(+434.0%)
PE Expansion Potential:
+434.0%
Last updated: January 30, 2026 4:02 PM ET
Data refreshes hourly during market hours. Next update: 5:02 PM
Data refreshes hourly during market hours. Next update: 5:02 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NIVF showing a specific setup today?
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$489 | 63 BUY |
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$238 | 54 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$140 | 54 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$17 | 52 HOLD |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$28 | 62 BUY |
Advanced NIVF Option Strategies
Professional options setups generated by AI based on today's NIVF price and gamma walls.
